AbbVie Inc. (ABBV) Dips 3.93% for July 11

Equities Staff  |

Among the S&P 500’s biggest fallers on Wednesday July 11 was AbbVie Inc. (ABBV). The stock experienced a 3.93% decline to $94.96 with 6.19 million shares changing hands.

AbbVie Inc. started at an opening price of 96.26 and hit a high of $97.50 and a low of $94.87. Ultimately, the stock took a hit and finished the day at $3.88 per share. AbbVie Inc. trades an average of 8.21 million shares a day out of a total 1.59 billion shares outstanding. The current moving averages are a 50-day SMA of $99.44 and a 200-day SMA of $98.84. AbbVie Inc. hit a high of $125.86 and a low of $69.38 over the last year.

AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

With its headquarters located in North Chicago, IL, AbbVie Inc. employs 29,000 people. After today’s trading, the company’s market cap has fallen to $150.69 billionAs for its value, has a P/E ratio of <24.9, a P/S of 6.92, a P/B of 42.39, and a P/FCF of 36.5.

Still paying commissions on stock trades? Equities.com now offers 100% commission free stock trading and flat-fee options trading for $89.95/month! Get started today by https://www.equities.com/trading

For all the attention paid to the Dow Jones Industrial Average (DJIA), it’s the S&P 500 that’s relied on by insiders and institutional investors. It represents the industry standard for American large-cap indices.

The Dow is made up of just 30 stocks to the S&P 500’s 500, and it uses an unreliable and outdated price-weighting system where the S&P 500 relies on market cap in weighting its returns. This is why its long-term returns is a much more reliable gauge for the performance of large- and mega-cap stocks over time.

To get more information on AbbVie Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: ABBV’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Investview Inc

Investview Inc is an investor technology and education company. It provides products that allow the individual investor to find, analyze, track, and manage their portfolio.